A Phase I, Open Label, Multicenter Trial of Oral Azacitidine (CC-486) Plus R-CHOP in Patients with High-Risk, Previously Untreated Diffuse Large B-Cell Lymphoma, Grade 3B Follicular Lymphoma, or Transformed Lymphoma

被引：0
|
作者：
Martin, Peter
Bartlett, Nancy L.
Rivera, Ildefonso Ismael Rodriguez
Revuelta, Maria
Chavez, Julio C.
Reagan, John L.
Smith, Sonali M.
LaCasce, Ann S.
Zhang, Lei
Zhai, Merry
Wu, Chengqing
Leonard, John P.
Cerchietti, Leandro
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
192
引用
收藏
页数：2
相关论文
共 50 条
  • [21] A randomized, open-label, Phase III study of obinutuzumab or rituximab plus CHOP in patients with previously untreated diffuse large B-Cell lymphoma: final analysis of GOYA
    Laurie H. Sehn
    Maurizio Martelli
    Marek Trněný
    Wenxin Liu
    Christopher R. Bolen
    Andrea Knapp
    Deniz Sahin
    Gila Sellam
    Umberto Vitolo
    Journal of Hematology & Oncology, 13
  • [22] Final Analysis of GOYA: A Randomized, Open-Label, Phase III Study of Obinutuzumab or Rituximab Plus CHOP in Patients with Previously Untreated Diffuse Large B-Cell Lymphoma
    Sahn, Laurie H.
    Martelli, Maurizio
    Trneny, Marek
    Liu, Wenxin
    Bolen, Christopher R.
    Knapp, Andrea
    Sahin, Deniz
    Sellam, Gila
    Vitolo, Umberto
    BLOOD, 2019, 134
  • [23] Phase II trial of split-dose R-CHOP for older patients with diffuse large B-cell lymphoma (DLBCL)
    Shah, Nirav Niranjan
    Szabo, Aniko
    Rajguru, Saurabh
    Devata, Sumana
    Howard, Mitch
    Pereira, Deepa
    Endres, Mariah
    Longo, Walter L.
    Hamadani, Mehdi
    Fenske, Timothy S.
    Fletcher, Christopher David
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [24] Integration of mutation analysis as a risk predictor in patients with diffuse large B-cell lymphoma treated with R-CHOP
    Song, Joo
    Perry, Anamarija
    Herrera, Alex F.
    Skrabek, Pamela
    Nasr, Michel
    Ottesen, Rebecca
    Nikowitz, Janet
    Chen, Lu
    Bedell, Victoria
    Murata-Collins, Joyce
    Chen, Yuan Yuan
    Li, Yuping
    Luna, Carlos Gomez
    McCarthy, Christine
    Pillai, Raju
    Wang, Jinhui
    Wu, Xiwei
    Zain, Jasmine
    Nademanee, Auayporn P.
    Niland, Joyce
    Gong, Qiang
    Chan, Wing Chung
    Weisenburger, Dennis D.
    MODERN PATHOLOGY, 2018, 31 : 556 - 556
  • [25] Integration of mutation analysis as a risk predictor in patients with diffuse large B-cell lymphoma treated with R-CHOP
    Song, Joo
    Perry, Anamarija
    Herrera, Alex F.
    Skrabek, Pamela
    Nasr, Michel
    Ottesen, Rebecca
    Nikowitz, Janet
    Chen, Lu
    Bedell, Victoria
    Murata-Collins, Joyce
    Chen, Yuan Yuan
    Li, Yuping
    Luna, Carlos Gomez
    McCarthy, Christine
    Pillai, Raju
    Wang, Jinhui
    Wu, Xiwei
    Zain, Jasmine
    Nademanee, Auayporn P.
    Niland, Joyce
    Gong, Qiang
    Chan, Wing Chung
    Weisenburger, Dennis D.
    LABORATORY INVESTIGATION, 2018, 98 : 556 - 556
  • [26] Preliminary Results from a Phase I Trial of Pembrolizumab Plus Vorinostat in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, and Hodgkin Lymphoma
    Herrera, Alex F.
    Chen, Lu
    Popplewell, Leslie L.
    Budde, Lihua E.
    Mei, Matthew
    Armenian, Saro H.
    Darrah, Justin
    Nikolaenko, Liana
    Chen, Robert W.
    Peters, Lacolle
    Kennedy, Neena
    Rosen, Steven
    Forman, Stephen J.
    Kwak, Larry W.
    BLOOD, 2019, 134
  • [27] A phase 2 study of venetoclax plus R-CHOP as first-line treatment for patients with diffuse large B-cell lymphoma
    Morschhauser, Franck
    Feugier, Pierre
    Flinn, Ian W.
    Gasiorowski, Robin
    Greil, Richard
    Illes, Arpad
    Johnson, Nathalie A.
    Larouche, Jean-Francois
    Lugtenburg, Pieternella J.
    Patti, Caterina
    Salles, Gilles Andre
    Trneny, Marek
    de Vos, Sven
    Mir, Farheen
    Samineni, Divya
    Kim, Su Y.
    Jiang, Yanwen
    Punnoose, Elizabeth
    Sinha, Arijit
    Clark, Emma
    Spielewoy, Nathalie
    Humphrey, Kathryn
    Bazeos, Alexandra
    Zelenetz, Andrew D.
    BLOOD, 2021, 137 (05) : 600 - 609
  • [28] Safety and efficacy of bevacizumab combined with R-CHOP regimen in seven Chinese patients with untreated diffuse large B-cell lymphoma
    Fu, Zhiying
    Zhu, Jun
    Zheng, Wen
    Liu, Weiping
    Ying, Zhitao
    Xie, Yan
    Wang, Xiaopei
    Lin, Ningjing
    Tu, Meifeng
    Ping, Lingyan
    Deng, Lijuan
    Zhang, Chen
    Ding, Ning
    Song, Yuqin
    CANCER CELL INTERNATIONAL, 2014, 14
  • [29] Phase 3 trial evaluating efficacy and safety of odronextamab plus CHOP vs rituximab plus CHOP in previously untreated diffuse large B-cell lymphoma (DLBCL; OLYMPIA-3).
    Matasar, Matthew
    Turgut, Burhan
    Tessoulin, Benoit
    Guidez, Stephanie
    Altuntas, Fevzi
    Iqbal, Nazia
    Namuduri, Manjusha
    Cao, Alice
    Sophos, Nickolas
    Uppala, Amulya
    Kargus, Katherine
    Zhu, Min
    Nolan, Siobhan
    Brouwer-Visser, Jurriaan
    Chaudhry, Aafia
    Ambati, Srikanth R.
    Mohamed, Hesham
    Tucker, David
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [30] Safety and efficacy of bevacizumab combined with R-CHOP regimen in seven Chinese patients with untreated diffuse large B-cell lymphoma
    Zhiying Fu
    Jun Zhu
    Wen Zheng
    Weiping Liu
    Zhitao Ying
    Yan Xie
    Xiaopei Wang
    Ningjing Lin
    Meifeng Tu
    Lingyan Ping
    Lijuan Deng
    Chen Zhang
    Ning Ding
    Yuqin Song
    Cancer Cell International, 14
12345